• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国人群2型糖尿病发生过程中的病理生理异质性。

Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.

作者信息

Kang Hahn Wook, Kim Dong Joon, Lee Myung-Shik, Kim Kwang-Won, Lee Moon-Kyu

机构信息

Department of Internal Medicine, Hallym Hospital, 900-4 Jakjen-Dong, Gyeyang-Ku, Inchon, Republic of Korea.

出版信息

Diabetes Res Clin Pract. 2005 Aug;69(2):180-7. doi: 10.1016/j.diabres.2004.12.011.

DOI:10.1016/j.diabres.2004.12.011
PMID:16005368
Abstract

OBJECTIVE

To investigate the clinical characteristics and predisposing metabolic abnormalities in the development of glucose intolerance and diabetes mellitus in obese and non-obese Korean subjects.

METHODS

Four hundred Korean subjects were classified into five groups according to degree of glucose tolerance by OGTT: NGT, IGT alone, IFG alone, IFG+IGT, and DM. The groups were also subdivided into obese and non-obese group according to body mass index. Insulin resistance was assessed by using homeostasis model assessment of insulin resistance (HOMA-R), and insulinogenic index was used as an index of early-phase insulin secretion.

RESULTS

Impaired early-phase insulin secretion was seen in non-obese IGT alone, IFG alone, and IFG+IGT, though more profound secretory defects were noted in IFG+IGT and DM. No significant difference were found in HOMA-R among non-obese IGT alone, IFG alone, or IFG+IGT, or in terms of early-phase insulin secretion in obese IGT alone, IFG alone, or IFG+IGT. However, the magnitude of insulin resistance differed in the obese group, IFG+IGT and DM being more insulin resistant than IGT alone or IFG alone.

CONCLUSIONS

These results suggest that the predisposing metabolic abnormality in non-obese subjects with IGT alone or IFG alone and in progression to IFG+IGT might be deterioration of early phase insulin secretion, whereas insulin resistance might be the major contributory factor in obese subjects. The predisposing metabolic abnormality leading to diabetes in both obese and non-obese groups was deterioration of early-phase insulin secretion.

摘要

目的

研究肥胖和非肥胖韩国受试者发生糖耐量异常和糖尿病时的临床特征及易患代谢异常。

方法

400名韩国受试者根据口服葡萄糖耐量试验(OGTT)的糖耐量程度分为五组:正常糖耐量(NGT)、单纯糖耐量受损(IGT)、单纯空腹血糖受损(IFG)、IFG+IGT以及糖尿病(DM)。根据体重指数,这些组又进一步分为肥胖组和非肥胖组。采用胰岛素抵抗稳态模型评估(HOMA-R)来评估胰岛素抵抗,并将胰岛素生成指数用作早期胰岛素分泌指标。

结果

单纯非肥胖IGT、单纯IFG以及IFG+IGT组均出现早期胰岛素分泌受损,不过IFG+IGT和DM组的分泌缺陷更为严重。单纯非肥胖IGT、单纯IFG或IFG+IGT组之间的HOMA-R无显著差异,单纯肥胖IGT、单纯IFG或IFG+IGT组在早期胰岛素分泌方面也无显著差异。然而,肥胖组的胰岛素抵抗程度有所不同,IFG+IGT和DM组比单纯IGT或单纯IFG组的胰岛素抵抗更强。

结论

这些结果表明,单纯IGT或单纯IFG的非肥胖受试者以及进展为IFG+IGT的易患代谢异常可能是早期胰岛素分泌恶化,而胰岛素抵抗可能是肥胖受试者的主要促成因素。肥胖和非肥胖组导致糖尿病的易患代谢异常均为早期胰岛素分泌恶化。

相似文献

1
Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.韩国人群2型糖尿病发生过程中的病理生理异质性。
Diabetes Res Clin Pract. 2005 Aug;69(2):180-7. doi: 10.1016/j.diabres.2004.12.011.
2
Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.糖耐量正常和1小时血糖过高受试者的代谢特征。
Clin Endocrinol (Oxf). 2008 Oct;69(4):575-9. doi: 10.1111/j.1365-2265.2008.03209.x. Epub 2008 Jan 31.
3
[Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].高血糖钳夹技术在评估糖耐量异常肥胖个体β细胞功能中的应用
Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1781-4.
4
Metabolic characteristics of glucose intolerance: the critical role of obesity.葡萄糖不耐受的代谢特征:肥胖的关键作用。
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):86-93. doi: 10.1055/s-2007-985382. Epub 2007 Oct 31.
5
Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.人类空腹血糖受损和餐后糖耐量受损的不同机制。
Diabetes Care. 2006 Aug;29(8):1909-14. doi: 10.2337/dc06-0438.
6
Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.日本糖耐量受损和新诊断2型糖尿病患者的胰岛β细胞功能及胰岛素敏感性
Metabolism. 2003 Apr;52(4):476-81. doi: 10.1053/meta.2003.50078.
7
[Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].[不同亚型糖耐量受损患者血糖波动特征]
Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):669-72.
8
Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.对意大利超重/肥胖儿童及青少年进行的口服葡萄糖耐量试验结果显示,空腹血糖受损的患病率非常高,但糖尿病患病率并不高。
Diabetes Metab Res Rev. 2009 Sep;25(6):528-34. doi: 10.1002/dmrr.980.
9
[The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population].[中国成年人群糖代谢异常亚类的分布特征]
Zhonghua Yi Xue Za Zhi. 2003 Dec 25;83(24):2128-31.
10
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.2 型糖尿病高危人群的代谢综合征:2 型糖尿病的遗传、病理生理学和演变(GENFIEV)研究。
Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):699-705. doi: 10.1016/j.numecd.2010.03.006. Epub 2010 Nov 5.

引用本文的文献

1
Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.在瑞典干预项目中,用于预测葡萄糖恶化和 2 型糖尿病发生风险的方程。
BMC Public Health. 2013 Oct 26;13:1014. doi: 10.1186/1471-2458-13-1014.
2
Adolescent build plotting on body composition chart and the type of diabetes mellitus.青少年体型绘制在身体成分图表上与糖尿病类型的关系。
J Korean Med Sci. 2012 Nov;27(11):1385-90. doi: 10.3346/jkms.2012.27.11.1385. Epub 2012 Oct 30.
3
Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m(2).
体重指数小于30kg/m²的胃癌患者行胃切除术后对2型糖尿病的影响。
J Korean Surg Soc. 2012 Jun;82(6):347-55. doi: 10.4174/jkss.2012.82.6.347. Epub 2012 May 29.
4
Efficacy and safety of vildagliptin/pioglitazone combination therapy in Korean patients with diabetes.维格列汀/吡格列酮联合治疗在韩国糖尿病患者中的疗效和安全性。
World J Diabetes. 2010 Nov 15;1(5):153-60. doi: 10.4239/wjd.v1.i5.153.